Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets.
about
Glucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolismArthroscopic debridement for knee osteoarthritisThe provocative lumbar facet jointAutoimmune response in cartilage-delivered peptides in a patient with osteoarthritisEstrogen receptor-alpha gene haplotype is associated with primary knee osteoarthritis in Korean populationIntra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of actionOctacalcium phosphate crystals directly stimulate expression of inducible nitric oxide synthase through p38 and JNK mitogen-activated protein kinases in articular chondrocytes.The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases.Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy - a reviewThe macrophages in rheumatic diseasesDiagnosis of osteoarthritis: imagingOsteoimmunology and the influence of pro-inflammatory cytokines on osteoclastsState-of-the-Art management of knee osteoarthritisNutraceuticals: potential for chondroprotection and molecular targeting of osteoarthritisAnti-inflammatory strategies in cartilage repairTraditional Chinese medicine in patients with osteoarthritis of the kneePrognostic biomarkers in osteoarthritisProinflammatory Cytokines Stimulate Mitochondrial Superoxide Flashes in Articular Chondrocytes In Vitro and In SituTissue inhibitor of metalloproteinases-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilageGinkgo biloba extract individually inhibits JNK activation and induces c-Jun degradation in human chondrocytes: potential therapeutics for osteoarthritisAnti-Osteoarthritic Effects of the Litsea japonica Fruit in a Rat Model of Osteoarthritis Induced by Monosodium IodoacetateEffect of low-level laser therapy on the expression of inflammatory mediators and on neutrophils and macrophages in acute joint inflammationGenomic analysis and differential expression of HMG and S100A family in human arthritis: upregulated expression of chemokines, IL-8 and nitric oxide by HMGB1Hormonal modulation of connective tissue homeostasis and sex differences in risk for osteoarthritis of the kneeEvidence for regulated interleukin-4 expression in chondrocyte-scaffolds under in vitro inflammatory conditionsReview of Prospects of Biological Fluid Biomarkers in Osteoarthritis.Role of fibroblast growth factor 8 (FGF8) in animal models of osteoarthritis.Meta-analysis of tumor necrosis factor alpha -308 polymorphism and knee osteoarthritis risk.Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksEfficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trialsEndothelial dysfunction and decreased vascular responsiveness in the anterior cruciate ligament-deficient model of osteoarthritis.Sphingosine-1-phosphate attenuates proteoglycan aggrecan expression via production of prostaglandin E2 from human articular chondrocytes.Cell-penetrating peptides released from thermosensitive nanoparticles suppress pro-inflammatory cytokine response by specifically targeting inflamed cartilage explants.Subchondral bone marrow lesions are highly associated with, and predict subchondral bone attrition longitudinally: the MOST study.Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis.Dickkopf-1 (Dkk-1) in plasma and synovial fluid is inversely correlated with radiographic severity of knee osteoarthritis patients.Concentration of cytokines in patients with osteoarthritis of the knee and fibromyalgia.Blocking ERK-1/2 reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein ACordycepin prevented IL-β-induced expression of inflammatory mediators in human osteoarthritis chondrocytesLow-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.
P2860
Q21284705-0B6226AE-B90C-47C5-AC9D-28F9332F26CEQ24242793-37B7E736-D9A2-4BEC-BCE0-6B99EB153818Q24657809-C8817A55-1EEA-48FA-B5F8-A335285401C4Q24793096-2CF590F8-747B-4E5E-A2D9-83DB471CE3F3Q24796581-40E16C01-F2E3-4D3D-88AB-FDAE6D5072F4Q24804189-2598E64F-3F46-47A1-B11C-D7909F79C983Q24812157-552BA0E0-DA30-47AD-A1B8-7B6266C96FEDQ24812406-A3AED2A6-CDAB-4490-9545-DC3BE35277B4Q26745714-8E55A3B3-8DE1-48C4-B5A6-58E0355257EEQ26765275-C44CBCEF-5210-46DD-BFF8-2ADEA14D44CAQ26828429-08CE8BE5-0C4B-4048-A836-FD9CB6BFBCA7Q26828486-15ACE907-7630-45F9-83F7-E1580C9B2C60Q26859086-5333C56B-CBBA-438D-81FC-AEEDBE13FE08Q26860861-ACE73652-AFB0-49D1-8CB9-4B899FCC2823Q26862600-DA69E70A-6D95-473D-9313-AF39C0726F6AQ27009255-731517A8-D3F0-4F11-93AB-CA863E13311AQ27022211-E9D45126-FF6D-4EAA-AED2-327D90226DB3Q27314567-6AE4D462-5AB7-47C4-ADF8-449485214D55Q28214460-FE24E783-2C9C-4767-98B3-D3D2D889C2FBQ28536785-46997CFA-3FF3-4896-86EA-8AE3C74689A5Q28547032-50C67088-FACD-45D5-9DA4-165A5941BF3AQ28580263-C312F0FB-D958-4B9E-A9BA-9D7450E15C84Q28655057-E26290A9-4870-4B9A-8AC4-FBC71244C5ACQ28706277-F4383CBD-C952-47D6-AA81-BD96BF8B783DQ28744330-52FCAADC-6143-4A27-B839-73375247744BQ30359055-D6EED3B0-0076-4F48-82AC-DD02CCC926F5Q30492900-0E6F3654-BA6E-457F-AF7A-112E0DEF0FD7Q30614213-4500BD2A-B3D5-426E-A9DC-E90E72E09140Q30629677-745A3C9C-DD29-43B8-BCA1-02295A4BC10EQ31142712-56774CB4-B54B-4021-ACF4-60CECE4BFA13Q33262584-29114366-9CA4-4CA3-9C1E-04A9AFDB0125Q33279463-AB30CEB5-3A45-4998-92DF-A7A7008B8833Q33552879-CCF6B66F-E2A7-4304-8E8F-4BF1F4355487Q33636382-45777661-2B53-42FF-A5CE-0FE297C6ACCFQ33637251-3DEFEEB7-A012-446C-9E40-470B68D7396FQ33742862-58888E67-0C65-4758-9502-669CC8B11940Q33769464-706B0AC2-EE67-451C-BF6F-34548D892DB0Q33793186-42CFBEC4-A1C3-460F-84CE-B8754EC13547Q33808621-A593BBA8-66C1-4D0B-A3A1-4507F2EFA1F3Q33880198-CCCE1A2A-731F-4936-8654-143ECA90D969
P2860
Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Osteoarthritis, an inflammator ...... on of new therapeutic targets.
@ast
Osteoarthritis, an inflammator ...... on of new therapeutic targets.
@en
Osteoarthritis, an inflammator ...... on of new therapeutic targets.
@nl
type
label
Osteoarthritis, an inflammator ...... on of new therapeutic targets.
@ast
Osteoarthritis, an inflammator ...... on of new therapeutic targets.
@en
Osteoarthritis, an inflammator ...... on of new therapeutic targets.
@nl
prefLabel
Osteoarthritis, an inflammator ...... on of new therapeutic targets.
@ast
Osteoarthritis, an inflammator ...... on of new therapeutic targets.
@en
Osteoarthritis, an inflammator ...... on of new therapeutic targets.
@nl
P2093
P2860
P1476
Osteoarthritis, an inflammator ...... on of new therapeutic targets.
@en
P2093
Abramson SB
Martel-Pelletier J
Pelletier JP
P2860
P304
P356
10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F
P577
2001-06-01T00:00:00Z